Heroin dependence and HIV infection in Malaysia

Chawarski, Marek C.; Mazlan, Mahmud

doi:10.1016/s0376-8716(06)80007-4

Cited by 43 publications

(37 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been reported that the cumulative number of HIV infections reported to the Ministry of Health Malaysia up to December 2005 was 70,559 cases with 8,179 positive for AIDS. Most (81.5%) of the HIV infected persons were young males (age 20-40 years) (1,6,7,9).…”

Section: Challenges To Treating Drug Addiction In Malaysiamentioning

confidence: 99%

See 1 more Smart Citation

A Fifty-Year Challenge in Managing Drug Addiction in Malaysia

Rusdi¹,

Robson²,

Muhammad³

et al. 2008

SSRN Journal

View full text Add to dashboard Cite

Section: Challenges To Treating Drug Addiction In Malaysiamentioning

confidence: 99%

“…The resulting economic, human resource and social loss is not quanti½ able as the vacuum left by these people in various employment sectors are currently being ½ lled by migrant workers. Thus, it is evident that the increasing trend in drug addiction poses a threat to the future of the nation (1,6,9).…”

Section: Introductionmentioning

confidence: 99%

A Fifty-Year Challenge in Managing Drug Addiction in Malaysia

Rusdi¹,

Robson²,

Muhammad³

et al. 2008

SSRN Journal

View full text Add to dashboard Cite

“…HIV risk behaviors were assessed using the AIDS/HIV Risk Inventory (ARI), (Chawarski, Pakes, & Schottenfeld, 1998) (Chawarski, Mazlan, & Schottenfeld, 2006) at baseline and after 12 and 24 weeks of buprenorphine/naloxone treatment. The ARI is a structured interview that includes an assessment of both drug-and sex-related HIV risk behaviors and questions regarding communicable diseases, non-injection drug use, and motivation to change.…”

Section: Data Collectionmentioning

confidence: 99%

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

Sullivan

Moore

Chawarski

et al. 2008

Journal of Substance Abuse Treatment

Self Cite

View full text Add to dashboard Cite

Methadone treatment reduces HIV risk but the effects of primary care-based buprenorphine/naloxone on HIV risk are unknown. The purpose of the current study was to determine whether primary carebased buprenorphine/naloxone was associated with decreased HIV risk behavior. We conducted a longitudinal analysis of 166 opioid dependent persons (129 men and 37 women) receiving buprenorphine/naloxone treatment in a primary care clinic. We compared baseline, 12 and 24-week overall, drug-related and sex-related HIV risk behaviors using the AIDS/HIV Risk Inventory (ARI). Buprenorphine/naloxone treatment was associated with significant reductions in overall and drugrelated ARI scores from baseline to 12 and 24-weeks. Intravenous drug use in the past 3 months was endorsed by 37%, 12%, and 7%, of patients at baseline, 12 weeks and 24 weeks, respectively; p < 0.001. Sex while you or your partner were "high" was endorsed by 64%, 13%, and 15% of patients at baseline, 12 weeks and 24 weeks, respectively; p<0.001. Inconsistent condom use during sex with a steady partner was high at baseline and did not change over time. We conclude that primary carebased buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk but additional efforts may be needed to address sex-related HIV risk when present. (ClinicalTrials.gov number, NCT00023283).

show abstract

“…[1][2][3][4][5][6][7] Until recently, Malaysia along with many other developing countries implemented a largely punitive approach to drug problems, relying on imprisonment or long-term detention in "rehabilitation" programs and prohibiting medical treatments for heroin dependence. 3,7 In Malaysia, the failure of this approach to stem drug problems and HIV transmission led to the introduction in 1996 of some medical treatments, including medically-supervised detoxification, drug counseling, and opioid antagonist maintenance treatment with naltrexone.…”

Section: Introductionmentioning

confidence: 99%

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Schottenfeld

Mazlan²

2008

The Lancet

Self Cite

View full text Add to dashboard Cite

Background-Expanding access to effective treatments for heroin dependence is a global health priority that will also reduce HIV transmission. This study compares the efficacy for maintaining heroin abstinence, preventing relapse, and reducing HIV risk behaviors of three common treatments: detoxification followed by drug counseling only or drug counseling combined with opioid antagonist (naltrexone) or agonist (buprenorphine) maintenance treatment.

show abstract

Heroin dependence and HIV infection in Malaysia

Cited by 43 publications

References 10 publications

A Fifty-Year Challenge in Managing Drug Addiction in Malaysia

A Fifty-Year Challenge in Managing Drug Addiction in Malaysia

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Contact Info

Product

Resources

About